SCHEMBL4014913

SCHEMBL4014913

CCCCc1nc(=O)c(-c2ccc(OC(C)C)cc2)c(C)n1Cc1ccc(-c2ccccc2C#N)cc1

nearest known ligand 0.49

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
PPARG P37231 8/20 0.49
ACHE P22303 1/20 0.44
AGTR1 P30556 2/20 0.42
AGTR2 P50052 1/20 0.41
KCNH2 Q12809 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4010868 0.95 PPARG (0.55) PPARGACHEAGTR2
SCHEMBL1890245 0.89 PPARG (0.50) PPARGACHEAGTR1
SCHEMBL4016615 0.88 PPARG (0.54) PPARGACHEAGTR1AGTR2
SCHEMBL4009715 0.87 PPARG (0.53) PPARGACHEAGTR1AGTR2
SCHEMBL4013553 0.86 PPARG (0.49) PPARGACHE
SCHEMBL4014315 0.85 PPARG (0.44) PPARGAGTR1AGTR2
SCHEMBL4012027 0.84 PPARG (0.63) PPARGACHEAGTR1AGTR2
SCHEMBL1889717 0.84 PPARG (0.56) PPARGACHEAGTR1
SCHEMBL4008828 0.83 AGTR1 (0.42) PPARGAGTR1AGTR2
SCHEMBL4017757 0.82 PPARG (0.60) PPARGACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009133970-A1 CRYSTALLINE COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-11-05 WO disclosed
EP-2074117-A2 HETEROMONOCYCLIC COMPOUND AND USE THEREOF Takeda Pharmaceutical Company Limited (JP) 2009-07-01 EP disclosed
WO-2008062905-A2 HETEROMONOCYCLIC COMPOUND AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-05-29 WO disclosed